Onconetix, Inc. ONCO
1.03
0.12
13.19%
as of 25 Sep
- Market cap
- $4.6M
- P/E
- 0.0×
Follow ONCO
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (105.23%) | (127.45%) | (127.79%) | (229.05%) |
+8 more TTM periods Free account |
|
| (57.37%) | (59.69%) | (58.49%) | (124.62%) | ||
ROIC |
(135.42%) | (120.73%) | (105.85%) | (1,126.14%) | |
Return on Tangible Assets |
(283.02%) | (774.32%) | 512.23% | 339.86% | |
Average Days of Receivables |
1.36 | 21.69 | 155.28 | 0.78 | |
Free Cash Flow per Share |
(4.60) | (155.81) | (514.81) | (267.10) | |
Free Cash Flow |
(10.31) | (9.80) | (9.68) | (7.51) | |
Piotroski F-Score |
4.00 | 5.00 | 4.00 | 5.00 | |
| Other line items | |||||
Cash ROIC |
(53.10%) | (63.38%) | (46.12%) | (178.25%) | |
Accounts Receivable Turnover |
88.48 | 24.51 | 4.38 | 24.33 | |
Accounts Payable Turnover |
0.06 | 0.07 | 0.07 | 0.06 | |
Inventory Turnover |
0.70 | 1.02 | 1.70 | 1.31 | |
Average Days of Payables |
5,319.02 | 3,735.04 | 3,515.40 | 3,687.19 | |
Days of Inventory on Hand |
606.60 | 335.27 | 300.00 | 309.82 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
11.66% | (5.41%) | (8.11%) | (7.41%) | |
Selling, General and Administrative Expense of Revenue |
1,258.88% | 1,007.62% | 863.86% | 667.71% | |
Share Based Compensation of Revenue |
6.78% | 9.15% | 9.11% | 33.54% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.01 | 0.98 | 0.62 | 0.15 | |
Depreciation/Fixed assets |
4.67 | 4.29 | 3.75 | 269.86 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
0.29 | 11.69 | 43.37 | 43.55 | |
Operating CF per Share |
(4.60) | (155.81) | (514.81) | (267.10) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(1,578.60%) | (1,364.04%) | (1,904.70%) | (4,154.71%) |
Columns are period end dates